Advanced Glycation End-Products and Diabetic Neuropathy of the Retina

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina

Diabetic retinopathy is a tissue-specific neurovascular impairment of the retina in patients with both type 1 and type 2 diabetes. Several pathological factors are involved in the progressive impairment of the interdependence between cells that consist of the neurovascular units (NVUs). The advanced...

Full description

Bibliographic Details
Main Author:	Toshiyuki Oshitari
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	diabetic retinopathy neurovascular unit advanced glycation end-products neuroprotection receptor of AGEs polyol pathway
Online Access:	https://www.mdpi.com/1422-0067/24/3/2927

Similar Items

The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina
by: Toshiyuki Oshitari
Published: (2021-08-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy
by: Leqaa A. Moemen, et al.
Published: (2020-04-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
by: Jing Xu, et al.
Published: (2018-07-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
by: Lin Mao, et al.
Published: (2022-08-01)

Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
by: Toshiyuki Oshitari
Published: (2023-08-01)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)

Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
by: Mariyam Khalid, et al.
Published: (2022-04-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

Receptor of advanced glycation end products in childhood asthma exacerbation
by: Adel Salah Bediwy, et al.
Published: (2016-01-01)

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
by: Yu Peng, et al.
Published: (2022-12-01)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
by: Shou-En Wu, et al.
Published: (2021-10-01)

The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
by: Sarah Louise Fishman, et al.
Published: (2018-11-01)

Do advanced glycation end products contribute to food allergy?
by: P. K. Smith, et al.
Published: (2023-04-01)

Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease
by: Li WY, et al.
Published: (2022-10-01)

Autophagy Plays a Protective Role in Advanced Glycation End Product-Induced Apoptosis in Cardiomyocytes
by: Pengfei Hu, et al.
Published: (2015-09-01)

Methylglyoxal, a highly reactive dicarbonyl compound, as a threat for blood brain barrier integrity
by: Eline Berends, et al.
Published: (2023-10-01)

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway
by: Liuyang Ren, et al.
Published: (2021-01-01)

Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes
by: James N. Tsoporis, et al.
Published: (2020-11-01)

Advanced Glycation End Products and Psoriasis
by: Martina Maurelli, et al.
Published: (2023-03-01)

Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
by: Xiaoyan Zhou, et al.
Published: (2018-02-01)

Colorimetric and fluorometric profiling of advanced glycation end products
by: Ammanath, Gopal, et al.
Published: (2022)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)

Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes
by: Mattabhorn Phimphilai, et al.
Published: (2021-08-01)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
by: Taehee Kim, et al.
Published: (2023-05-01)

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
by: Hiroyasu Mori, et al.
Published: (2019-09-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

Serum Levels of Antibodies to Advanced Glycation End Products in Patients with Type 2 Diabetes Mellitus and Hypertension
by: Asparuh Nikolov, et al.
Published: (2020-06-01)

The effect of protein oxidation on the formation of advanced glycation end products after chicken myofibrillar protein glycation
by: Zongshuai Zhu, et al.
Published: (2023-09-01)

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
by: Cheng YZ, et al.
Published: (2014-11-01)

Advanced glycation end products of dietary origin and their association with inflammation in diabetes – A minireview
by: Pedreanez Adriana, et al.
Published: (2024-01-01)

Collateral Glucose-Utlizing Pathwaya in Diabetic Polyneuropathy
by: Hiroki Mizukami, et al.
Published: (2020-12-01)